HOMECONTACTSITE MAPSEARCH

Stock Information
NASDAQ:INFI
$5.01   + 0.04
Sep 2, 2010
4:00 PM ET
Quotes delayed at least 20 minutes. Data provided by eSignal.
Investors and Media Relations

Infinity is an innovative drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult to treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity’s programs in the inhibition of the Hsp90 chaperone system, the Hedgehog pathway, fatty acid amide hydrolase and phosphoinositol-3-kinase (PI3-kinase) are evidence of its innovative approach to drug discovery and development.


Events

Aug 5, 2010
BMO Capital Markets 10th Annual Focus on Healthcare Conference

Aug 4, 2010
Infinity Pharmaceuticals Second Quarter 2010 Results

more »

Annual Report


Click here to view the 2009 Annual Report PDF


Recent Releases

Aug 4, 2010
Infinity Highlights R&D Progress and Announces Second Quarter 2010 Financial Results

Jul 29, 2010
Infinity to Present at BMO Healthcare Conference

more »

Request Investor Kit
Shareholder Briefcase
Receive Email Alerts
Subscribe to News
Search
© 2001-2010 Infinity Pharmaceuticals, Inc. All rights reserved. | Terms | Forward Looking Statements | Privacy